Two Sigma Investments’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Two Sigma Investments’s Portfolio TCRR Stock Details TCRR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-36,000	Closed	-$54K	–	3413
2023 Q1	$54K	Sell	36,000 -84,677	-70%	-$114K	﹤0.01%	2745
2022 Q4	$121K	Sell	120,677 -170,891	-59%	-$230K	﹤0.01%	2485
2022 Q3	$525K	Sell	291,568 -38,089	-12%	-$110K	﹤0.01%	1755
2022 Q2	$956K	Sell	329,657 -410,122	-55%	-$1.01M	﹤0.01%	1567
2022 Q1	$2.04M	Sell	739,779 -24,625	-3%	-$77.5K	0.01%	1346
2021 Q4	$3.56M	Buy	764,404 +442,545	+137%	+$2.77M	0.01%	1430
2021 Q3	$2.74M	Buy	321,859 +63,413	+25%	+$896K	0.01%	1691
2021 Q2	$4.24M	Sell	258,446 -39,879	-13%	-$806K	0.01%	1299
2021 Q1	$6.59M	Buy	298,325 +188,534	+172%	+$5.14M	0.02%	907
2020 Q4	$3.4M	Buy	109,791 +99,473	+964%	+$2.52M	0.01%	1155
2020 Q3	$210K	Buy	+10,318	New	+$181K	﹤0.01%	2795

Two Sigma Investments's TCRR Position: Q2 2023 in Review

Two Sigma Investments sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q2 2023, closing a stake of 36,000 shares — an estimated $54K sold.

Two Sigma Investments first reported a position in TCRR in Q3 2020 and held it in 11 quarters. The position peaked at $6.59M in Q1 2021. 0 funds tracked by Wall St. Rank hold TCRR as of Q2 2023.

Two Sigma Investments reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Two Sigma Investments sold 36,000 TCR2 Therapeutics Inc. Common Stock shares in Q2 2023, an estimated $54K.
Two Sigma Investments first reported a position in TCR2 Therapeutics Inc. Common Stock in Q3 2020 and held it in 11 quarters.
Two Sigma Investments's TCR2 Therapeutics Inc. Common Stock position peaked at $6.59M in Q1 2021.
0 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.